Nurix Data Scientist Interview: Questions, Experience & Prep (2026)

Nurix is a clinical-stage biotechnology company focused on targeted protein degradation and the development of novel small molecule therapies. Their data science team works at the intersection of machine learning and drug biology, making this one of the more specialised data science tracks you can pursue in 2026. As of July 2026, Nurix has 7 open Data Scientist roles, which signals active team growth across functions.

Candidates typically go through a recruiter screening call, a take-home or live technical assessment, and one or more rounds covering machine learning theory, biological data case studies, and cross-functional communication. The exact structure can vary by team, so treat every detail here as a general pattern based on what candidates report publicly rather than a fixed process.

For broader context, the knok jobradar counted 937 Data Scientist openings across India around the same period, with Bangalore leading at 166 roles, followed by Delhi at 46 and Hyderabad at 27. Salary ranges vary widely by experience level. See our Data Scientist salary guide for a full breakdown by city and company tier.

These questions are drawn from publicly reported interview experiences and the nature of Nurix's work in AI-driven drug discovery. Expect a strong emphasis on applied ML, biological data challenges, and your ability to communicate findings to mixed audiences.

1. How would you build a model to predict drug-target binding affinity from molecular features?
2. Walk us through a project where you handled high-dimensional biological or scientific data.
3. How do you approach feature engineering when working with molecular or protein sequence data?
4. Explain the difference between gradient boosting and random forests. When would you pick one over the other?
5. How do you handle class imbalance, especially in biological datasets where positive examples (active compounds) are very rare?
6. Describe how you would validate a machine learning model intended for a drug discovery pipeline without leaking information across similar compounds.
7. How would you explain a complex model result to a biology team with no ML background?
8. What experience do you have with graph neural networks or other architectures suited to molecular graph data?
9. How do you decide when a model is ready to hand off versus when to keep improving it?
10. Tell me about a time a model you built failed or underperformed. What did you do next?
11. How would you design an experiment to confirm that a new feature or architecture actually improves your model?
12. Which Python libraries or tools do you use for cheminformatics or bioinformatics tasks, and how deeply have you used them?

Q: Walk us through a project where you handled high-dimensional biological or scientific data.

*Situation:* I was working on a genomics project where each sample had gene expression readings across a very large panel of genes, and the labelled dataset had only a few hundred samples.

*Task:* My goal was to build a classifier to identify which patients were likely to respond to a particular treatment, and to make the results interpretable enough for the clinical team to act on.

*Action:* I started with variance-based filtering to remove obviously uninformative features, then applied PCA to reduce dimensionality before training. I used cross-validation carefully given the small sample size, and compared L1-regularised logistic regression against gradient boosting to see which generalised better. I also worked closely with the biology team to add curated pathway-level features alongside the raw expression values, since domain knowledge pointed to specific signalling pathways as likely relevant.

*Result:* The regularised model outperformed our baseline on held-out data. More importantly, the pathway features became a direct talking point for the biology team, who used them to form new hypotheses. The project was presented at an internal review and led to a funded follow-up study.

---

Q: Tell me about a time a model you built failed or underperformed. What did you do?

*Situation:* I built a compound activity prediction model that performed well on our internal validation set but dropped sharply when tested on a new chemical series the team had just synthesised.

*Task:* I needed to understand the root cause quickly, fix what I could, and communicate the issue honestly to the project team before they made synthesis decisions based on wrong predictions.

*Action:* I ran a data distribution analysis and found that the new chemical series occupied a different region of chemical space from the training set. This was a classic out-of-distribution problem, not a bug in the model itself. I flagged this to the team immediately, then worked on two things: adding uncertainty estimation so the model could signal low confidence on distant compounds, and requesting that additional labelled examples from the new series be prioritised for the next assay batch.

*Result:* The team appreciated the transparency and adjusted their expectations for which compound types the model could reliably score. Adding uncertainty output became a standing requirement for all predictive models on the project after that incident.

---

Q: How would you explain a complex model result to a biology team with no ML background?

*Situation:* I had trained a graph neural network on molecular graphs, and the biology team needed to understand why certain compounds were flagged as high priority before committing synthesis resources.

*Task:* I had to present results in a way that was actionable for scientists who think in terms of functional groups and assay data, not attention weights and embedding dimensions.

*Action:* I used atom-level attention weights to create visualisations that highlighted which parts of each molecule the model focused on. I translated these into chemistry language: 'the model consistently scores compounds higher when this ring system is present, which lines up with what your SAR data already shows.' I avoided discussing architecture details entirely and kept the focus on where the model agreed with expert intuition versus where it diverged.

*Result:* The biology team became active partners in model review sessions. They started flagging disagreements between the model and their intuition, which helped us catch two mislabelled training samples and refine our feature set over the following sprint.

For machine learning design questions, use a Problem, Data, Model, Evaluation structure. Start by restating what you are predicting and why it matters for the business or scientific goal, describe what data you would want and its likely quirks (imbalance, noise, small sample size), outline your modelling approach with a justification for that choice, and end with how you would measure success in a way the team can act on. This shows you think end-to-end rather than jumping straight to an algorithm name.

For statistical or experimental design questions, lead with the hypothesis you are testing, explain how you would control for confounders, describe your test choice and your thinking on sample size, and discuss what a result in either direction would mean for next steps. Candidates who hedge appropriately when data is limited come across as more trustworthy than those who give overconfident answers.

For failure or challenge questions, use STAR but make sure the Result section includes what you learned and what concretely changed afterward. Interviewers at companies like Nurix are often more interested in your diagnostic thinking than in the outcome itself. A model that failed but taught the team something valuable is a stronger story than a model that 'went well' with no details.

For communication questions, structure your answer around your audience first. What does this person care about? What decisions do they need to make? Then describe how you translated technical output into those terms. Concrete examples, such as using atom-level visualisations or mapping model outputs to domain terminology, are much stronger than abstract claims about 'simplifying things.'

For tool and library questions, be honest about your depth of experience. Saying 'I have used RDKit for basic featurisation but I am newer to DeepChem' is a stronger answer than overclaiming, especially in a company where domain scientists will work alongside you.

Based on what candidates report, Nurix interviewers are looking for a combination of rigorous ML thinking and the ability to work productively with domain scientists who are not ML practitioners. A few themes come up consistently.

Domain awareness matters more here than at a typical tech company. You do not need a PhD in chemistry or biology, but you should be able to discuss molecular representations, why biological datasets are often small and noisy, and what makes validation tricky in drug discovery (such as data leakage when similar compounds appear in both train and test sets). Candidates who treat this like a generic ML role tend to get caught on these questions.

Communication is tested directly. Many candidates report being asked to explain a result or a model choice to a non-technical audience, either as a standalone question or embedded in a case study. Practice translating ML concepts into biological terms before your interview, not after.

Intellectual honesty is valued over polish. In drug discovery, overconfident models cause real downstream costs in failed synthesis and wasted assay capacity. Interviewers want to see that you can recognise model limitations, communicate uncertainty, and push back when a result does not make scientific sense.

Coding and statistics are still assessed. Expect questions or exercises covering Python, pandas, and core statistical concepts. SQL may come up depending on the team. The bar is solid, practical competence rather than competitive programming speed.

Week 1: Core ML and statistics review
Revise the fundamentals that come up in nearly every data science interview: bias-variance tradeoff, regularisation, cross-validation, and model selection criteria. Work through a few classification problems with imbalanced data using real code. Candidates report that Python proficiency across pandas, scikit-learn, and matplotlib is assessed at every stage of the process.

Week 2: Drug discovery and biological data context
Read introductory material on how ML is applied in drug discovery, covering topics like QSAR modelling, molecular fingerprints, and the basics of targeted protein degradation. You do not need deep domain expertise, but you should be able to discuss these ideas at a conceptual level during the interview. Familiarity with RDKit is a plus. Public papers from Nurix or comparable companies (Recursion, Schrödinger, Insilico Medicine) give useful context for the kinds of problems these teams work on.

Week 3: Communication and case practice
Practice explaining your past projects out loud using STAR structure. Focus especially on the Result section: what changed because of your work? Prepare a short version (roughly 2 minutes) and a longer version (roughly 5 minutes) of your two or three strongest projects. Ask a colleague to play the role of a sceptical biologist and practice translating your ML work into non-technical terms in real time.

Week 4: Mock interviews and logistics
Do at least two timed mock technical interviews under realistic conditions. Review any take-home assessment instructions very carefully before starting. Candidates report that write-up quality and clarity of reasoning matter as much as the code itself. Check that your GitHub or portfolio reflects your strongest work, and update your resume to highlight projects involving scientific, biological, or high-dimensional data.

Ignoring the biology context entirely. Candidates who treat this like a generic ML interview often get caught when asked about validation strategy or data-specific quirks. Even a basic understanding of why compound datasets are hard to split correctly goes a long way toward signalling that you will be a useful partner to the science team.

Overclaiming model performance. In drug discovery, overfitting is a well-known trap. If you describe past projects with suspiciously clean results and no caveats, interviewers will probe hard. Proactively mention how you guarded against data leakage or overfitting. This actually builds credibility rather than reducing it.

Not asking clarifying questions on open-ended design problems. Questions like 'build a model to predict binding affinity' have many valid interpretations depending on data availability, success criteria, and deployment context. Jumping straight to an answer without clarifying constraints reads as shallow. Ask first.

Weak STAR answers with no observable result. If your Result is 'the project went well' or 'the team was happy,' you are leaving the interviewer with nothing concrete to evaluate. Tie results to something observable, even if qualitative: a model adopted into a workflow, a hypothesis validated, a process that changed because of your analysis.

Underselling communication experience. Many technical candidates skip over how they explained results to non-technical stakeholders. For a company like Nurix, where data scientists work daily with biologists and chemists, this is a genuine job requirement. Treat communication examples as equal in importance to technical ones when preparing your stories.